One-anastomosis gastric bypass (OAGB) versus Roux-en-Y gastric bypass (RYGB) as revisional procedures after failed laparoscopic sleeve gastrectomy (LSG): systematic review and meta-analysis of comparative studies
verfasst von:
Antonio Vitiello, Giovanna Berardi, Roberto Peltrini, Pietro Calabrese, Vincenzo Pilone
The aim of this study was to compare weight loss and gastroesophageal reflux disease (GERD) remission after one-anastomosis gastric bypass (OAGB) versus Roux-en-Y gastric bypass (RYGB) as revisional procedures after laparoscopic sleeve gastrectomy (LSG).
Methods
In PubMed, Embase, and Cochrane Library, a search was performed using the terms “Roux-en-Y gastric bypass versus one anastomosis gastric bypass,” “revisional surgery,” and
“sleeve gastrectomy.” Only original articles in English language comparing OAGB and RYGB were included. No temporal interval was set. The primary outcome measure was weight loss (%TWL). The secondary endpoints were leak, bleeding, marginal ulcer, and GERD. PRISMA flowchart was used. Differences in continuous and dichotomous outcome variables were expressed as mean difference (MD) and risk difference (RD) with 95% CI, respectively. Heterogeneity was assessed by using I2 statistic.
Results
Six retrospective comparative articles were included in the present meta-analysis. Weight loss analysis showed a MD = 5.70 (95% CI 4.84–6.57) in favor of the OAGB procedure with a statistical significance (p = 0.00001) and no significant statistical heterogeneity (I2 = 0.00%). There was no significant RD for leak, bleeding, or marginal ulcer after the two revisional procedures. After conversion to OAGB, remission from GERD was 68.6% (81/118), and it was 80.6% (150/186) after conversion to RYGB with a RD = 0.10 (95% CI −0.04, 0.24), no statistical significance (p = 0.19), and high heterogeneity (I2
= 96%). De novo GERD was 6.3% (16/255) after conversional OAGB, and it was 0.5% (1/180) after conversion to RYGB with a RD = −0.23 (95% CI −0.57, 0.11), no statistical significance (p = 0.16), and high heterogeneity (I2
= 92%).
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Introduction
Laparoscopic sleeve gastrectomy (LSG) is currently the most performed bariatric procedure worldwide [1]. Despite this popularity, LSG was reported to be associated with weight regain and gastroesophageal reflux disease (GERD) in the long-term with a revision rate up to 36% [2]. Some articles have also described intestinal metaplasia (Barrett’s disease) after LSG due to the chronic exposure of the lower esophagus to reflux [3, 4]. Roux-en-Y gastric bypass (RYGB) and one-anastomosis gastric bypass (OAGB) are, respectively, the second and the third most performed interventions, and they have both been suggested as good options for failed LSG [2‐5]. Specifically, RYGB is considered an efficient treatment for GERD post-LSG [6], while OAGB may provide better results in terms of further weight loss [7].
The aim of this study was to analyze and compare weight loss and GERD remission after OAGB versus RYGB as revisional procedures after LSG.
Anzeige
Methods
Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines were followed [8].
Literature search
In PubMed, Embase, and Cochrane Library, a search was performed using the terms “Roux-en-Y gastric bypass versus one anastomosis gastric bypass,” “revisional surgery,” and “sleeve gastrectomy.” In addition, the reference lists of all retrieved articles were manually reviewed. According to Problem/Population, Intervention, Comparison, and Outcome (PICO) framework, study selection criteria were exactly defined. Only original articles in English language comparing OAGB and RYGB were included. No temporal interval was set. The primary outcome measure was weight loss. The secondary endpoints were leak, bleeding, GERD remission, and de novo reflux. The last search was performed in December 2022.
Studies selection
Two independent authors analyzed each article and performed data extraction independently. Duplicate studies were removed. In case of disagreement, further investigation was conducted by an additional author.
Statistical analysis
DataRev software (Cochrane) version 5.4.1 (the Cochrane Collaboration 2011, the Nordic Cochrane Centre, Copenhagen) was used to perform a random-effect meta-analysis with Mantel–Haenszel calculation because of the observational nature of most studies included in this analysis.
Anzeige
Differences in continuous and dichotomous outcome variables were expressed as mean difference and risk difference (RD) with 95% CI, respectively. Heterogeneity was assessed by using I2 statistic, which describes the percentage of total variation across studies that is due to heterogeneity rather than chance. Usually, values of the I2 statistic < 25% are indicative of low heterogeneity, those ranging between 25 and 75% of moderate heterogeneity, and those > 75% of high heterogeneity. I2 < 40% was considered as non-important heterogeneity. A p < 0.05 was considered statistically significant. Publication bias was assessed through visual inspection of funnel plots.
Quality assessment
The Newcastle–Ottawa Quality Assessment Scale (NOS) [9] was used as an assessment tool to evaluate case–control studies. The scale’s range varies from 0 to 9 stars, and studies with a score equal to or higher than 5 were considered to have an adequate methodological quality to be included.
Results
The literature search found 55 articles. After removal of 21 duplicates, other 27 articles were excluded because they were not comparing RYGB and OAGB as revisional procedures. Seven [10‐15] papers were considered eligible, but one [16] was excluded due to incomplete report of the outcome measures. PRISMA flow chart for the study selection is shown in Fig. 1. Eventually, 5 retrospective articles and 1 randomized controlled trial were included in our meta-analysis (Table 1). In total, 739 patients were included, of which 373 (50.5%) underwent OAGB and 366 (49.5%) underwent RYGB. The sample size of these studies ranged from 55 to 263 patients. The primary outcome measure was reported both as percentage of total weight loss (%TWL) and percentage of excess weight loss (%EWL) or excess BMI loss percent (%EBMIL) with a follow-up ranging from 12 to 60 months; assessment with NOS showed high-quality methodology for all the considered papers (Table 2).
Fig. 1
PRISMA flowchart
Table 1
Included studies and baseline characteristics
Study (year)
Primary surgery
Revisional surgery
Patient (n)
Age (years)
Male (n)
BMI at conversion (kg/m2)
Max follow-up time (months)
BMI at follow-up (kg/m2)
Chiappeta (2019)
LSG
OAGB
34
46.76 ± 11.48
11
45.7 ± 8
12
36.6 ± 6.3
RYGB
21
46.14 ± 10.8
2
36.6 ± 6.9
12
33.5 ± 5.6
Rayman (2021)
LSG
OAGB
144
42.4 ± 10.5
37
41.6 ± 5.7
25.5
31.8 ± 5.3
RYGB
119
44.3 ± 11.8
35
39.6 ± 5.0
35
33.3 ± 5.0
Felsenreich (2022)
LSG
OAGB
13
-
-
45.0 ± 7.3
15
31.4 ± 8.1
RYGB
45
-
-
38.6 ± 8.6
15
30.3 ± 8.5
Rheinwalt (2022)
LSG
OAGB
55
42 ± 1.3
33
45.5 ± 1.0
24
35
RYGB
68
46 ± 1.2
39.3 ± 1.0 kg
24
31
Wilczyński (2022)
LSG
OAGB
47
45.02 ± 10.71
13
40.44 ± 5.8
60
-
RYGB
33
41.24 ± 8.906
6
38.70 ± 6.84
60
-
Hany (2022)
LSG
OAGB
80
42.6 ± 7.1
11
45.1 ± 8.3
24
27.4 ± 3.1
RYGB
80
43.4 ± 7.5
11
44.9 ± 6.6
24
27.8 ± 2.2
Table 2
Outcomes of the included studies
Study (year)
Revisional surgery
Operative time (min)
Sample (n)
Leaks (n, %)
Bleeding (n, %)
Marginal ulcer (n, %)
EWL%
TWL%
T2DM resolution (%)
HTN resolution (%)
GERD on follow-up (%)
NOS
Chiappeta (2019)
OAGB
79 ± 36
34
0 (0%)
0 (0%)
0 (0%)
29 ± 13
15.8 ± 7.8
100%
66.7%
11.8%
9
RYGB
98 ± 24
21
0 (0%)
0 (0%)
1 (4.8%)
22 ± 18
10.3 ± 7.6
60%
0%
4.8%
Rayman (2021)
OAGB
-
144
2 (1.4%)
2(1.4%)
0 (0%)
58.7
32 ± 9
-
-
17.4%
9
RYGB
-
119
1 (1.7%)
3 (2.5%)
0 (0%)
44.2
27 ± 9
-
-
7.6%
Felsenreich (2022)
OAGB
-
13
0 (0%)
0 (0%)
0 (0%)
80.3 ± 23.7
39.5 ± 11.5
-
-
28.9%
9
RYGB
-
45
0 (0%)
0 (0%)
0 (0%)
79.8 ± 34.1
37.7 ± 14.6
-
-
53.8%
Rheinwalt (2022)
OAGB
168 ± 7.2
55
2 (3.6%)
0 (0%)
0 (0%)
50
24 ± 2.6
92%
92%
13.34%
8
RYGB
201 ± 6.8
68
4 (5.9%)
2 (2.9%)
0 (0%)
40
18 ± 3.0
100%
89%
11.1%
Wilczyński (2022)
OAGB
-
47
0 (0%)
1 (2.12%)
3 (6.4.%)
84.04 ± 18.81
21.81 ± 12.48
97.3%
27.3%
28.6%
8
RYGB
-
33
0 (0%)
1 (3%)
4 (12.1%)
72.95 ± 20.3
18.39 ± 11.85
33.3%
30%
60%
Hany (2022)
OAGB
85.6 ± 18.6
80
0 (0%)
1 (1.25%)
0 (0%)
-*
-*
75%
68%
-
8
RYGB
104.9 ± 13.7
80
0 (0%)
1 (1.25%)
2 (2.5%)
-*
-*
71%
75%
-
NOS Newcastle–Ottawa Scale. T2SM type 2 diabetes. HTN hypertension. *Hany et al. reported weight loss as %EBMIL
×
Weight loss was reported using different parameters, but percentage of total weight loss (%TWL) was used in five studies showing a MD = 5.70 (95% CI 4.84–6.57) in favor of the OAGB procedure with a statistical significance (p < 0.001) and no significant statistical heterogeneity (I2 = 0%) (Fig. 2).
Fig. 2
Forest plot for percentage of total weight loss
×
Overall leak rate after conversion to OAGB was 1% (4/373), and it was 1.6% (6/366) after revision to RYGB.
Meta-analysis showed a RD = − 0.00 (95% CI − 0.02–0.02) with no statistical significance (p = 0.83) and no significant statistical heterogeneity (I2 = 0.00%) (Fig. 3).
Fig. 3
Forest plot for leak
×
Total bleedings after revisional OAGB and RYGB were 1.3% (5/373) and 2.2% (8/366), respectively, with a RD = − 0.01 (95% CI − 0.03, 0.01) with no statistical significance (p = 0.33) and no significant statistical heterogeneity (I2 = 0.00%) (Fig. 4).
Fig. 4
Forest plot for bleeding
×
Total percentage of marginal ulcers after conversion to OAGB was 0.8% (3/373), and it was 1.9% (7/366) after revision to RYGB. Meta-analysis showed a RD = − 0.01 (95% CI − 0.02, 0.01) with no statistical significance (p = 0.51) and low heterogeneity (I2 = 16%) (Fig. 5).
Fig. 5
Forest plot for marginal ulcer
×
Anzeige
GERD was the indication for conversion for 31.6% (118/373) of patients before OAGB and for 50.8% (186/366) before RYGB. Meta-analysis of rate of preconversional GERD showed a RD = − 0.24 (95% CI − 0.41, − 0.06) with statistical significance (p = 0.007) and high heterogeneity (I2 = 87%) (Fig. 6).
Fig. 6
Forest plot for GERD as indication for conversion
×
After conversion to OAGB remission from GERD was 68.6% (81/118), and it was 80.6% (150/186) after conversion to RYGB with a RD = 0.10 (95% CI − 0.04, 0.24) with no statistical significance (p = 0.19) and high heterogeneity (I2 = 96%) (Fig. 7).
Fig. 7
Forest plot for GERD after conversion
×
De novo GERD was 6.3% (16/255) after conversional OAGB, and it was 0.5% (1/180) after conversion to RYGB with a RD = − 0.23 (95% CI − 0.57, 0.11) with no statistical significance (p = 0.16) and high heterogeneity (I2 = 92%) (Fig. 8).
Fig. 8
Forest plot for de novo GERD after conversion
×
Funnel plots inspection did not show significant bias (Supplement materials 1–6).
Anzeige
Discussion
LSG was initially introduced by Marceau [17] and Gagner [18] proposed as a first step of a staged procedure in patients with BMI > 60 kg/m [2]. Since postoperative outcomes demonstrated low morbidity and satisfactory weight loss, LSG became a stand-alone bariatric intervention [19]. Short-term studies (1–3 years) reported an excess weight loss (%EWL) comparable to the values of the RYGB [20]. Mid-term reports (5–7 years) have shown less successful results, with a certain percentage of weight regain [21, 22]; the SM-BOSS [23] study showed that excess BMI loss peaked at 2 years after SG (74.7%) but decreased by the end of the fifth year to 61.1%.
Recently, long-term studies have demonstrated a worrisome rate of conversion and GERD [24], especially in individuals with BMI > 50 kg/m2 [25]. Sporadic cases of vitamin deficiency after LSG have been also published [26].
A recent systematic review showed a rate of de novo GERD of 20% [27] after LSG, while a meta-analysis found that the increase of postoperative GERD was 19%, and de novo reflux occurred in 23% [28] of patients.
Despite several meta-analyses have investigated the role of OAGB and RYGB as revisional procedures after failed restrictive surgery [6, 7, 29], there is a lack of comparative studies on the role of this interventions specifically after failed LSG. Chiappetta et al. [10] first reported their single-center analysis of 55 patients showing that OAGB after failed SG was a quicker procedure with less perioperative complications. On the contrary, Rayman [12] reported that conversion of LSG to OAGB, compared to RYGB, resulted in increased weight loss with a higher rate of GERD and potential nutritional deficiencies. Instead, Felsenreich et al. [11] have recently concluded that with regard to the fact that OAGB has a low potential to cure patients from GERD symptoms after SG, RYGB is probably the best option for patients post-LSG reflux. Rheinwalt [13] also found comparable results with significantly shorter operation times for OAGB. After a follow-up of 5 years, Wilczyński[14] reported a significant remission of T2DM after OAGB when compared to RYGB after LSG. Hany et al. [15] have performed the only available controlled trial demonstrating that after 2 years, both revisional RYGB and OAGB have comparable metabolic outcomes.
Anzeige
Our analysis has demonstrated a low-to-moderate heterogeneity among these studies with a high-quality methodology. Weight loss as TWL%, EWL%, or %EBMIL and rates of early complications (leak, bleeding) were reported in all the papers. Regardless of the used parameter, the mean weight loss after one-anastomosis gastric bypass was higher than after RYGB in all but one of the included articles; thus, the present meta-analysis confirmed the inferiority of RYGB in terms of weight loss. Only Rheinwalt [13] found that the two interventions induced comparable weight loss probably for the long biliopancreatic limb of the RYGB in this study.
Low rates of early complications (leak, bleeding) found in all the collected papers demonstrated the feasibility and safety of revisional surgery after LSG.
Regarding long-term complications, some authors have reported a higher occurrence of marginal ulcer (MU) after revisional surgery [30] especially due to the risk of retained gastric antrum syndrome (RGA) after conversion to gastric bypass [31, 32]. Conversely, in this systematic review, after a follow-up ranging from 12 to 60 months, the rate of MU was 1% both for RYGB and OAGB.
As expected, we found that a higher rate of patients with GERD after LSG was converted to RYGB rather than to OAGB, but remission from GERD was satisfactory and comparable after the two procedures. Even if de novo GERD occurred more frequently after revisional OAGB, new-onset reflux and Barrett’s disease were reported after both revisional interventions.
Strength and limitations
Although a meta-analysis [33] was recently published, the present includes two more papers (6 instead of 4) and focuses not only on weight loss but also on the safety (early complications) and on GERD symptoms after revision. The main limitation is that GERD was assessed through different diagnostic methods with a lack of information on severity of GERD, presence and size of eventual hiatal hernia, and degree of esophagitis. Moreover, several revisional procedures were performed together with a concomitant hiatoplasty, which may have influenced the results on reflux. This is particularly interesting for the treatment of patients with severe obesity suffering from GERD and/or hiatal hernia (HH). Even if from 22 to 37% of class three obesity patients have a hiatal hernia (HH) [34], these defects are preoperatively underdiagnosed or not repaired intraoperatively. Conversely, studies with long-term results have demonstrated that SG plus hiatal hernia repair (HHR) induces symptoms relief up to 60% of patients [35]. Considering that GERD itself is a major issue before and after SG, HHR should be considered mandatory for those with severe obesity and GERD undergoing sleeve gastrectomy. Eventually, we must acknowledge that weight loss is mostly influenced by the length of the biliopancreatic limb; therefore, future studies comparing OAGB and RYGB after LSG should take into account the bypassed lengths of small bowel.
Conclusion
Conversion from LSG to RYGB or OAGB is feasible and safe with a low rate of postoperative complications.
Despite weight loss is satisfactory after both procedures, OAGB provides better results. Remission from GERD is higher after RYGB but without statistical significance.
Without knowing the applied bypass length in most of the analyzed studies, OAGB might be a better option for failed LSG, while RYGB still should be preferred in case of severe GERD.
Declarations
Ethics approval
This report does not describe any study with human participants or animals performed by any of the authors.
Competing interests
The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Mit der Zeitschrift Die Chirurgie erhalten Sie zusätzlich Online-Zugriff auf weitere 43 chirurgische Fachzeitschriften, CME-Fortbildungen, Webinare, Vorbereitungskursen zur Facharztprüfung und die digitale Enzyklopädie e.Medpedia.
Bis 30. April 2024 bestellen und im ersten Jahr nur 199 € zahlen!
One-anastomosis gastric bypass (OAGB) versus Roux-en-Y gastric bypass (RYGB) as revisional procedures after failed laparoscopic sleeve gastrectomy (LSG): systematic review and meta-analysis of comparative studies
verfasst von
Antonio Vitiello Giovanna Berardi Roberto Peltrini Pietro Calabrese Vincenzo Pilone
Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.
In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.
Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.
Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.
Update Chirurgie
Bestellen Sie unseren Fach-Newsletterund bleiben Sie gut informiert.
Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.
Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?
Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.
